Company profile for Galera Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. We leverage our expertise in superoxide dismutase mimetics to design drugs to reduce normal tissue toxicity from radiotherapy and to increase the anti-cancer efficacy of radiotherapy. Our lead product candidate, GC4419, is a potent...
We are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. We leverage our expertise in superoxide dismutase mimetics to design drugs to reduce normal tissue toxicity from radiotherapy and to increase the anti-cancer efficacy of radiotherapy. Our lead product candidate, GC4419, is a potent and highly selective small molecule dismutase mimetic we are initially developing for the reduction of severe oral mucositis (SOM).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2 West Liberty Boulevard, Suite 110 Malvern, PA 19355
Telephone
Telephone
610-725-1500
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/22/3170932/0/en/Galera-Therapeutics-Announces-Acquisition-of-Dismutase-Mimetics-Portfolio-by-Toronto-based-Biossil-for-up-to-105-Million.html

GLOBENEWSWIRE
22 Oct 2025

https://www.globenewswire.com/news-release/2024/12/31/3003077/0/en/Galera-Therapeutics-completes-acquisition-of-Nova-Pharmaceuticals.html

GLOBENEWSWIRE
01 Jan 2025

https://www.globenewswire.com/news-release/2024/12/31/3003077/0/en/Galera-Therapeutics-completes-acquisition-of-Nova-Pharmaceuticals.html

GLOBENEWSWIRE
31 Dec 2024

https://www.globenewswire.com/news-release/2024/08/14/2929907/0/en/Galera-Announces-Board-Approval-of-Complete-Liquidation-and-Dissolution.html

GLOBENEWSWIRE
14 Aug 2024

https://www.fiercebiotech.com/biotech/gone-are-days-galera-biotech-says-good-bye-staffers-and-initiates-wind-down

FIERCE BIOTECH
14 Aug 2024

https://www.globenewswire.com/news-release/2024/05/13/2880268/0/en/Galera-Reports-First-Quarter-2024-Financial-Results-and-Recent-Corporate-Updates.html

GLOBENEWSWIRE
13 May 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty